In conclusion, we developed and validated a multiparametric prognostic model to predict IDH mutation status in glioma using MR Radiomics features combined with clinical factor and MRI quantitative parameters, which showed improved performance over the model using only conventional MRI or Radiomic features. The gene discussed is IDH1; the disease is central nervous system cancer.